Skip to navigation | Skip to main content | Skip to footer
Menu
Menu Search the University of Manchester siteSearch
Search type

Alternatively, use our A–Z index

Dr Richard Warren (BSc (Hons), MBChB (Hons), MRCP, PhD) - publications

List of publications

2016

  • Yiu, Z., Warren, R., & Menter, A. (2016). Introduction. In R. Warren, & A. Menter (Eds.), Handbook of Psoriasis and Psoriatic Arthritis. (pp. 1-5). Switzerland: Springer International Publishing. DOI: 10.1007/978-3-319-18227-8_1. Publication link: cb3f04de-0def-4214-8007-e8fe67ffe192
  • Chisholm, A., Pearce, C. J., Chinoy, H., Warren, R. B., & Bundy, C. (2016). Distress, misperceptions, poor coping and suicidal ideation in psoriatic arthritis: a qualitative study. Rheumatology, 55(6), 1047-1052. DOI: 10.1093/rheumatology/kew009. Publication link: c316c157-c100-4d8f-ada8-f9bc3bcddb7e | PubMed:26961743
  • Theodorakopoulou, E., Yiu, Z., Bundy, C., Chularojanamontri, L., Gittins, M., Jamieson, L. A., ... Griffiths, C. (2016). Early and late onset psoriasis: a cross-sectional clinical and immunocytochemical investigation. British Journal of Dermatology. DOI: 10.1111/bjd.14886. Publication link: dee2ff74-5ecb-4b1c-9d3a-00accc4f213d | PubMed:27459949
  • Yesudian, P. D., Leman, J., Balasubramaniam, P., Macfarlane, A. W., Al-Niaimi, F., Griffiths, C. E. M., ... Warren, R. B. (2016). Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis. Journal of Drugs in Dermatology, 15(3), 345-349. . Publication link: e68c7215-ea6d-47f1-9d1c-f40d71560a32 | PubMed:26954320
  • Rungapiromnan, W., Yiu, Z., Warren, R., Griffiths, C., & Ashcroft, D. (2016). Impact of Biologic Therapies on Risk of Major Adverse Cardiovascular Events in Patients with Psoriasis: Systematic Review and Meta-analysis of Randomised Controlled Trials. British Journal of Dermatology. DOI: 10.1111/bjd.14964. Publication link: fa8c3c4a-7d99-4302-9ca8-3e644390450b | PubMed:27518205
  • Ray-Jones, H., Eyre, S., Barton, A., & Warren, R. B. (2016). One SNP at a Time: Moving beyond GWAS in Psoriasis.The Journal of investigative dermatology, 136(3), 567-573. DOI: 10.1016/j.jid.2015.11.025. Publication link: f987af9c-ef5e-4522-afa3-9b9c96cff499 | PubMed:26811024
  • Smith, R. L., Hébert, H. L., Massey, J., Bowes, J., Marzo-Ortega, H., Ho, P., ... Warren, R. B. (2016). Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis. Archives of Dermatological Research, 308(3), 201-205. DOI: 10.1007/s00403-016-1620-4. Publication link: 1f976e46-e5d6-43ca-9d36-50c22f1e45dd | PubMed:26830904
  • Yiu, Z., Exton, L. S., Jabbar-Lopez, Z., Mohd Mustapa, M. F., Samarasekera, E., Burden, D., ... Warren, R. (2016). Risk of serious infections during use of biologic therapies for psoriasis: a systematic review. In Pharmacoepidemiology and Drug Safety . (Suppl 3 ed., Vol. 25, pp. 437-438). Publication link: 1855a022-56b9-4648-8099-fb96837a71e5
  • Iskandar, I., Warren, R., Evans, I., Mcelhone, K., Owen, C. M., Burden, A. D., ... Griffiths, C. E. M. (2016). Patterns of biological therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists’ Biologic Interventions Register. 9. Abstract from The 96th British Association of Dermatologists Annual Meeting, Birmingham, United Kingdom.. Publication link: 04beca79-68fd-44a6-805d-a2409f442a70
  • Yiu, Z., Exton, L. S., Jabbar-Lopez, Z., Mohd Mustapa, M. F., Samarasekera, E. J., Burden, A. D., ... Warren, R. (2016). Risk of serious infections in patients with psoriasis on biologic therapies: a systematic review and meta-analysis. Journal of Investigative Dermatology, 136(8), 1584-1591. DOI: 10.1016/j.jid.2016.03.035. Publication link: 0f8a1035-f3d7-4831-b832-5929087b69e1 | PubMed:27085754
  • Iskandar, I., Ashcroft, D., Warren, R., Evans, I., Mcelhone, K., Owen, C. M., ... Griffiths, C. (2016). Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).British Journal of Dermatology. DOI: 10.1111/bjd.15027. Publication link: 34501b46-2866-432f-aec1-6f196cb3d44f
  • Warren, R., Mrowietz, U., Kiedrowski, R. V., Niesmann, J., Wilsmann-Theis, D., Ghoreschi, K., ... Reich, K. (2016). A 52-week double-blind placebo-controlled study of an intensified dosing schedule of subcutaneous methotrexate in patients with moderate-to-severe plaque-type psoriasis (METOP). The Lancet. . Publication link: 5f54bc83-406e-4c54-b058-128cc0b2caaf
  • Iskandar, I., Warren, R., Evans, I., Mcelhone, K., Owen, C. M., Burden, A. D., ... Ashcroft, D. (2016). A real world comparison of methods for assessing dosing patterns of biologic therapies for psoriasis. 3-681. Abstract from 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland.DOI: 10.1002/pds.4070. Publication link: 98adce11-2b2d-41c3-893c-a28b48fdba1e
  • Iskandar, I. Y. K., Warren, R., Lunt, M., Mcelhone, K., Smith, C. H., Reynolds, N. J., ... Ashcroft, D. (2016). Impact of biologic therapies on quality of life of psoriasis patients: results from the British Association of Dermatologists Biologic Interventions Register. In Journal of Investigative Dermatology. (Issue 9, Supplement 2 ed., Vol. 136, pp. S161-S294). DOI: 10.1016/j.jid.2016.06.035. Publication link: 8434c0bc-3698-46ad-8a89-0f1f2883aee7
  • Iskandar, I., Warren, R., Evans, I., Mcelhone, K., Owen, C. M., Burden, A. D., ... Ashcroft, D. (2016). A real world comparison of methods for assessing dosing patterns of biologic therapies for psoriasis. In Pharmacoepidemiology and Drug Safety . ((Suppl 3) ed., Vol. 25, pp. 273-274). Publication link: 8371a872-cad8-4e65-8201-e0d0a23d8281
  • Rungapiromnan, W., Warren, R., Yiu, Z., Griffiths, C. E. M., & Ashcroft, D. (2016). Risk of major adverse cardiac events associated with biologic therapies in patients with plaque psoriasis: systematic review and meta-analysis of randomised controlled trials. In Pharmacoepidemiology and Drug Safety . (Suppl 3 ed., Vol. 25, pp. 536-537). DOI: 10.1002/pds.4070. Publication link: 7d858de0-4542-4349-8ce3-120365614d1d

2015

  • Iskandar, I. Y. K., Ashcroft, D. M., Warren, R. B., Yiu, Z. Z. N., Mcelhone, K., Lunt, M., ... Griffiths, C. E. M. (2015). Demographics and disease characteristics of psoriasis patients enrolled in the British Association of Dermatologists Biologic Interventions Register (BADBIR).The British journal of dermatology, 173(2), 510-518. DOI: 10.1111/bjd.13908. Publication link: ae50de6e-db17-4e08-9df8-d25a465d9726 | PubMed:25989336
  • Warren, R. B., Smith, C. H., Yiu, Z. Z. N., Ashcroft, D. M., Barker, J. N. W. N., Burden, A. D., ... Griffiths, C. E. M. (2015). Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).The Journal of investigative dermatology, 135(11), 2632-2640. DOI: 10.1038/jid.2015.208. Publication link: cded3aed-6bd6-410f-b41f-1c93ac24393b | PubMed:26053050
  • Yiu, Z. Z. N., & Warren, R. B. (2015). Efficacy and safety of emerging immunotherapies in psoriasis.Immunotherapy, 7(2). DOI: 10.2217/imt.14.101. Publication link: ed7b3b04-f558-4ca9-b3e4-2914d9448eb2 | PubMed:25713988
  • Hébert, H. L., Bowes, J., Smith, R. L., Flynn, E., Parslew, R., Alsharqi, A., ... Warren, R. B. (2015). Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions.The British journal of dermatology, 172(4), 933-939. DOI: 10.1111/bjd.13340. Publication link: fe1c9022-419a-4b31-adee-32058d445e7c | PubMed:25124732
  • Griffiths, C. E. M., Barnes, M. R., Burden, A. D., Nestle, F. O., Reynolds, N. J., Smith, C. H., ... PSORT Consortium (2015). Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy. The Journal of investigative dermatology, 135(12), 2903-7. DOI: 10.1038/jid.2015.286. Publication link: 9dcd6f18-7384-4955-b6df-8a58d2a1f653 | PubMed:26569580
  • Ellingford, J. M., Black, G. C. M., Judge, M., Clayton, T. H., Griffiths, C. E. M., & Warren, R. B. (2015). A novel mutation in IL36RN underpins childhood pustular dermatosis.Journal of the European Academy of Dermatology and Venereology : JEADV. DOI: 10.1111/jdv.13034. Publication link: 98a6ad05-6bb1-4566-af09-97edb75ccdea | PubMed:25688670
  • Bowes, J., Budu-Aggrey, A., Huffmeier, U., Uebe, S., Steel, K., Hebert, H., ... Barton, A. (2015). Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.Nature communications, 6, [6046]. DOI: 10.1038/ncomms7046. Publication link: 8d4d25cd-b041-48e4-80ce-80c9f7b88014 | PubMed:25651891
  • Jani, M., Chinoy, H., Warren, R. B., Griffiths, C. E. M., Plant, D., Morgan, A. W., ... Barton, A. (2015). Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis.Lancet (London, England), 385 Suppl 1. DOI: 10.1016/S0140-6736(15)60363-4. Publication link: 7c902e19-1174-422f-ad50-fa7aa08df17f | PubMed:26312870
  • Reich, K., Zschocke, I., Bachelez, H., de Jong, E. M. G. J., Gisondi, P., Puig, L., ... Mrowietz, U. (2015). Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.Journal of the European Academy of Dermatology and Venereology : JEADV, 29(6). DOI: 10.1111/jdv.12774. Publication link: 136b0c6e-021d-4d18-b719-29a4be5fdc9f | PubMed:25346093
  • Foulkes, A., & Warren, R. (2015). Pharmacogenomics and the resulting impact on psoriasis therapies. Dermatologic Clinics, 33(1), 149-60. DOI: 10.1016/j.det.2014.09.011. Publication link: 32d11239-1f8a-491f-9d23-3fc086c1334d | PubMed:25412789
  • Jani, M., Chinoy, H., Warren, R. B., Griffiths, C. E. M., Plant, D., Fu, B., ... BRAGGSS., . U. (2015). Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.Arthritis & rheumatology (Hoboken, N.J.), 67(8), 2011-2019. DOI: 10.1002/art.39169. Publication link: 52a86356-e59d-468a-ade9-1cef4a97948e | PubMed:26109489

2014

  • Lynch, M., Kirby, B., & Warren, R. B. (2014). Treating moderate to severe psoriasis - Best use of biologics. Expert Review of Clinical Immunology, 10(2), 269-279. DOI: 10.1586/1744666X.2014.873701. Publication link: 4313862e-576e-4cb5-b65d-f9f9e4d780ff | PubMed:24372444
  • Hébert, H. L., Bowes, J., Smith, R. L., McHugh, N. J., Barker, J. N. W. N., Griffiths, C. E. M., ... Warren, R. B. (2014). Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. Journal of Investigative Dermatology, 134(5), 1459-1462. DOI: 10.1038/jid.2013.485. Publication link: 30edd265-ec8e-4246-9a1a-b9df9035f039 | PubMed:24217014
  • Horner, M. E., Abramson, A. K., Warren, R. B., Swanson, S., & Menter, M. A. (2014). The spectrum of oculocutaneous disease: Part I. Infectious, inflammatory, and genetic causes of oculocutaneous disease. Journal of the American Academy of Dermatology, 70(5), 795-e25. DOI: 10.1016/j.jaad.2013.12.013. Publication link: 1c9677b9-3cf8-49f8-b99d-b619014430e7 | PubMed:24742848
  • Mrowietz, U., De Jong, E. M. G. J., Kragballe, K., Langley, R., Nast, A., Puig, L., ... Warren, R. B. (2014). A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology, 28(4), 438-453. DOI: 10.1111/jdv.12118. Publication link: 79cc5db7-1a89-4c9c-91b9-3d0ef49425be | PubMed:23437792
  • Jani, M., Barton, A., Warren, R. B., Griffiths, C. E. M., & Chinoy, H. (2014). The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatology, 53(2), 213-222. [ket260]. DOI: 10.1093/rheumatology/ket260. Publication link: 7e327757-a794-4b41-a00d-d45a8e620262 | PubMed:23946436
  • Yiu, Z. Z. N., Griffiths, C. E. M., & Warren, R. B. (2014). Safety of biological therapies for psoriasis: Effects on reproductive potential and outcomes in male and female patients. British Journal of Dermatology, 171(3). DOI: 10.1111/bjd.13060. Publication link: 6a48c028-d3cf-4822-ba8b-9b4836c24f44 | PubMed:24749725
  • Coates, L. C., Walsh, J., Haroon, M., Fitzgerald, O., Aslam, T., Al Balushi, F., ... Helliwell, P. S. (2014). Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care & Research, 66(9), 1410-1416. DOI: 10.1002/acr.22284. Publication link: 9ace0204-50db-498e-bd6f-2924af69715c | PubMed:24470406
  • Massey, J., Wedderburn, L. R., Vencovský, J., Danko, K., Lundberg, I. E., Padyukov, L., ... Lamb, J. A. (2014). Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. Annals of the Rheumatic Diseases, 73(9), 1750-1752. DOI: 10.1136/annrheumdis-2014-205440. Publication link: a39936a3-937f-423f-8adf-fe5bb9ae28dc | PubMed:24812289
  • Foulkes, A. C., Wheeler, L., Gosal, D., Griffiths, C., & Warren, R. B. (2014). Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis. The British journal of dermatology, 170(1), 206-9. DOI: 10.1111/bjd.12572. Publication link: b21cbff1-6431-4cbb-8d16-49aac587a3c5 | PubMed:23909440

2013

2012

2011

2010

2009

2008

2007

2006

2005